跳至主要内容
临床试验/NCT00263419
NCT00263419Unknown不适用

Psychosoziale Intervention Zur Reduktion Diabetischer Spätschäden Bei Diabetes Mellitus Typ 2

Heidelberg University2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2005年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
110
试验地点
2
主要终点
Progression of albuminuria

研究概览

简要总结

The purpose of this study is to determine whether a structured stress relief management program can prevent the progression of late diabetic complications in patients with type 2 diabetes.

详细描述

Patients with type 2 diabetes and increased albumin excretion have an increased risk of renal failure and cardiovascular events. It has recently been shown, that psychosocial stress is an additional major risk factor contributing to the increased risk of cardiac events. However, it is not clear, whether a structured stress-relief training of patients reduces the risk of micro- and macrovascular damage in type 2 diabetes.

Comparisons: Conventional treatment of diabetes according to national guidelines is compared to conventional treatment plus structured stress relief management training.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes Type 2
  • Albuminuria
  • Age 30-70

排除标准

  • Diabetes duration < 3 years
  • Preexisting non-diabetic kidney
  • Psychiatric disorders
  • Alcohol or drug abuse
  • Malignant tumors or hematologic disorders
  • Heart failure NYHA III-IV
  • Acute coronary syndrome

结局指标

主要结局

Progression of albuminuria

时间窗: 1,2,3,4 and 5 year

次要结局

  • Mortality(3,4 and 5 years)
  • Late diabetic complications (micro-macrovascular)(1,2,3,4 and 5 years)
  • Cardiovascular Events(1, 2,3,4 and 5 years)
  • Nuclear Factor kappa B as marker of psychosocial stress(1,2,3,4 and 5 years)
  • Quality of life(post intervention, 1,2,3,4 and 5 years)
  • Psychological symptoms(post intervention, 1,2,3,4 and 5 years)
  • Cardiovascular risk factors(post intervention, 1,2,3,4 and 4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefan Kopf MD

Prof. P.P. Nawroth & Dr. med S. Kopf

Heidelberg University

研究点 (2)

Loading locations...

相似试验